Preparation of a flexible binucleating ligand, xylylene-bridged biscyclam α,α′-bis(1,4,8,11-tetraazacyclotetradecan-6-yl)-p-xylene and structure of its dinickel(II) complex
摘要:
A binucleating ligand, xylylene-bridged biscyclam alpha,alpha'-bis(1,4,8,11-tetraazacyclotetradecan-6-yl)-p-xylene ((cyclam)(2)-p-xyl) was prepared from alpha,alpha'-dichloro-p-xylene, diethylmalonate and 1,4,8,11-tetraazaundecane in three steps. The second step, aminolytic condensation of the tetraamine was critical. The ligand yielded a dinickel(II) complex {Ni2(cyclam)(2)-p-xyl}(ClO4)(4).4H(2)O. X-ray crystal analysis of the complex disclosed opposite and almost perpendicular occupation of the macrocycles to the bridging benzene ring through equatorial connection at the 6-carbons. Crystal data: tetragonal space group P4(2), a=15.251(2), c=9.821(2) Angstrom, V=2284.3(6) Angstrom(3), Z=2. It is anticipated that conformational change in solution due to free rotation around the methylene carbon at the junction puts the macrocycles into face-to-face location with Ni-Ni distance of similar-to-7.7 Angstrom.
LINKED CYCLIC POLYAMINES WITH ACTIVITY AGAINST HIV
申请人:JOHNSON MATTHEY PUBLIC LIMITED COMPANY
公开号:EP0619813A1
公开(公告)日:1994-10-19
JP3375961B2
申请人:——
公开号:JP3375961B2
公开(公告)日:2003-02-10
[EN] LINKED CYCLIC POLYAMINES WITH ACTIVITY AGAINST HIV
申请人:JOHNSON MATTHEY PUBLIC LIMITED COMPANY
公开号:WO1993012096A1
公开(公告)日:1993-06-24
(EN) Linked cyclic polyamines of formula: Z - R - A - R' - Y, where Z and Y are each cyclic polyamine moieties, A is an aromatic or heteroaromatic moiety, and R and R' are each an alkylene chain or heteroatom-containing chain, show high activity against HIV, and low toxicity, in $i(in vivo) tests. Novel compounds, and pharmaceutical compositions are claimed.(FR) Des polyamines cycliques liées de la formule: Z - R - A - R' - Y, dans laquelle Z et Y représentent chacun des fractions de polyamine cyclique, A représente une fraction aromatique ou hétéroaromatique, et R et R' représentent chacun une chaîne alkylène ou une chaîne contenant un hétéroatome, présentent une activité élevée contre le VIH, alliée à une faible toxicité, au cours de tests $i(in vitro). De nouveaux composés et de nouvelles compositions pharmaceutiques sont revendiqués.